These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2517294)

  • 1. High-dose follicle-stimulating hormone (FSH) ovarian stimulation in low-responder patients for in vitro fertilization.
    Hofmann GE; Toner JP; Muasher SJ; Jones GS
    J In Vitro Fert Embryo Transf; 1989 Oct; 6(5):285-9. PubMed ID: 2517294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
    Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
    Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicle-stimulating hormone/luteinizing hormone ratio as an independent predictor of response to controlled ovarian stimulation.
    Kofinas JD; Elias RT
    Womens Health (Lond); 2014 Sep; 10(5):505-9. PubMed ID: 24807379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of using follicle-stimulating hormone preparations depleted of luteinizing hormone to achieve follicular growth in in vitro fertilization.
    Agrawal R; Conway GS; Engmann L; Bekir JS; Jacobs HS
    Gynecol Endocrinol; 1998 Feb; 12(1):9-15. PubMed ID: 9526704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the flare-up protocol with high dose human follicle stimulating hormone and human menopausal gonadotropins for in vitro fertilization in poor responders.
    Padilla SL; Dugan K; Maruschak V; Shalika S; Smith RD
    Fertil Steril; 1996 Apr; 65(4):796-9. PubMed ID: 8654641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders.
    Lainas TG; Sfontouris IA; Venetis CA; Lainas GT; Zorzovilis IZ; Tarlatzis BC; Kolibianakis EM
    Hum Reprod; 2015 Oct; 30(10):2321-30. PubMed ID: 26307091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
    Damario MA; Barmat L; Liu HC; Davis OK; Rosenwaks Z
    Hum Reprod; 1997 Nov; 12(11):2359-65. PubMed ID: 9436663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of basal serum follicle stimulating hormone, luteinizing hormone and oestradiol concentrations following pituitary down-regulation in predicting ovarian response to stimulation with highly purified follicle stimulating hormone.
    Develioglu OH; Cox B; Toner JP; Oehninger S; Muasher SJ
    Hum Reprod; 1999 May; 14(5):1168-74. PubMed ID: 10325255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian stimulation for in vitro fertilization using pure follicle-stimulating hormone with and without gonadotropin-releasing hormone agonist in high-responder patients.
    Edelstein MC; Brzyski RG; Jones GS; Oehninger S; Sieg SM; Muasher SJ
    J In Vitro Fert Embryo Transf; 1990 Jun; 7(3):172-6. PubMed ID: 2116488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
    Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
    Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN; Phung HT; Ho MT
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose follicle-stimulating hormone stimulation at the onset of the menstrual cycle does not improve the in vitro fertilization outcome in low-responder patients.
    Karande VC; Jones GS; Veeck LL; Muasher SJ
    Fertil Steril; 1990 Mar; 53(3):486-9. PubMed ID: 2106455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Useful predictors of ovarian stimulation response in women undergoing in vitro fertilization.
    van der Stege JG; van der Linden PJ
    Gynecol Obstet Invest; 2001; 52(1):43-6. PubMed ID: 11549863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH.
    Balasch J; Fábregues F; Peñarrubia J; Carmona F; Casamitjana R; Creus M; Manau D; Casals G; Vanrell JA
    Hum Reprod; 2006 Jul; 21(7):1884-93. PubMed ID: 16517559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous LH surge versus hCG as ovulation trigger after low-dose highly purified FSH in IUI: a comparison of 761 cycles.
    Romeu A; Monzó A; Peiró T; Diez E; Peinado JA; Quintero LA
    J Assist Reprod Genet; 1997 Oct; 14(9):518-24. PubMed ID: 9401870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome.
    Scott RT; Toner JP; Muasher SJ; Oehninger S; Robinson S; Rosenwaks Z
    Fertil Steril; 1989 Apr; 51(4):651-4. PubMed ID: 2494082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recruitment of follicles by recombinant human follicle-stimulating hormone commencing in the luteal phase of the ovarian cycle.
    Rombauts L; Suikkari AM; MacLachlan V; Trounson AO; Healy DL
    Fertil Steril; 1998 Apr; 69(4):665-9. PubMed ID: 9548155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the efficiency of controlled ovarian hyperstimulation in the gonadotropin-releasing hormone agonist-suppression cycle using the initial follicle count during gonadotropin stimulation.
    Huang FJ; Chang SY; Tsai MY; Kung FT; Wu JF; Chang HW
    J Assist Reprod Genet; 2001 Feb; 18(2):91-6. PubMed ID: 11285987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone.
    Balasch J; Miró F; Burzaco I; Casamitjana R; Civico S; Ballescá JL; Puerto B; Vanrell JA
    Hum Reprod; 1995 Jul; 10(7):1678-83. PubMed ID: 8582960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.